Pullover and save a life

Hoxworth closes out April With a special gift for blood donors

Hoxworth Blood Center, University of Cincinnati, closes out April with an exclusive gift for all blood donors. 

Donors who roll up a sleeve at a Hoxworth Neighborhood Donor Center between Monday, April 25 and Friday, April 29 will receive a Hoxworth quarter-zip pullover.

“Every day, patients in local hospitals need blood and platelets to survive traumas, organ transplants, and cancer treatments,” said Alecia Lipton, director of public relations at Hoxworth Blood Center. “Because blood cannot be manufactured in a lab, blood donors are needed to roll up a sleeve to save lives in their community.”

Lipton added that Hoxworth Blood Center needs to collect more than 450 units of blood daily to meet the demands of area hospitals. 

Appointments for blood donation are highly encouraged. Donors can schedule appointments by calling (513) 451-0910 or by scheduling online at www.hoxworth.org

About Hoxworth:
Hoxworth Blood Center, University of Cincinnati, was founded in 1938, and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home. 

Related Stories

1

Sugar overload killing hearts

November 10, 2025

Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.

2

App turns smartwatch into detector of structural heart disease

November 10, 2025

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.